Why are biotech investors suddenly so exuberant? What does it mean when a CEO scrubs his LinkedIn profile? And can CRISPR turn your dog into a winged hellhound bent on destroying Chicago?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Stick around for a parsing of merger mania, a history lesson on biotech breakups, and the story of how a sleepy little cancer conference became a multimillion-dollar business. Also STAT reporter Megan Thielking joins us to talk about how Dwayne “The Rock” Johnson has brought gene editing to the big screen, and Adam mentions Four Loko.
For more on the topics we cover, here’s the EP Vantage story on M&A; here’s something on a CEO manicuring his LinkedIn; and, most importantly, here’s STAT’s review of “Rampage.”
We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email firstname.lastname@example.org.